Nasdaq

2025 Annual Report Vistin Pharma ASA

24-04-2026

Oslo, Norway, 24 April 2026

Please find attached the Annual Report for 2025 for Vistin Pharma ASA (VISTN). There is no material changes in the financial statement compared to the preliminary full year result presented on 12 February 2026.

The annual report for 2025 will also be made available on www.vistin.com.

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
Alexander.karlsen@vistin.com

 

Attachments